Gene Therapy-based Drug and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Gene Therapy-based Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Therapy-based Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Therapy-based Drug Overall Market Size
2.1 Global Gene Therapy-based Drug Market Size: 2021 VS 2028
2.2 Global Gene Therapy-based Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene Therapy-based Drug Players in Global Market
3.2 Top Global Gene Therapy-based Drug Companies Ranked by Revenue
3.3 Global Gene Therapy-based Drug Revenue by Companies
3.4 Top 3 and Top 5 Gene Therapy-based Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gene Therapy-based Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Therapy-based Drug Players in Global Market
3.6.1 List of Global Tier 1 Gene Therapy-based Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene Therapy-based Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Gene Therapy-based Drug Market Size Markets, 2021 & 2028
4.1.2 Viral Gene Delivery System
4.1.3 Non-viral Gene Delivery System
4.2 By Type - Global Gene Therapy-based Drug Revenue & Forecasts
4.2.1 By Type - Global Gene Therapy-based Drug Revenue, 2017-2022
4.2.2 By Type - Global Gene Therapy-based Drug Revenue, 2023-2028
4.2.3 By Type - Global Gene Therapy-based Drug Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene Therapy-based Drug Market Size, 2021 & 2028
5.1.2 Neurological Diseases
5.1.3 Cancer
5.1.4 Other
5.2 By Application - Global Gene Therapy-based Drug Revenue & Forecasts
5.2.1 By Application - Global Gene Therapy-based Drug Revenue, 2017-2022
5.2.2 By Application - Global Gene Therapy-based Drug Revenue, 2023-2028
5.2.3 By Application - Global Gene Therapy-based Drug Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Gene Therapy-based Drug Market Size, 2021 & 2028
6.2 By Region - Global Gene Therapy-based Drug Revenue & Forecasts
6.2.1 By Region - Global Gene Therapy-based Drug Revenue, 2017-2022
6.2.2 By Region - Global Gene Therapy-based Drug Revenue, 2023-2028
6.2.3 By Region - Global Gene Therapy-based Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Gene Therapy-based Drug Revenue, 2017-2028
6.3.2 US Gene Therapy-based Drug Market Size, 2017-2028
6.3.3 Canada Gene Therapy-based Drug Market Size, 2017-2028
6.3.4 Mexico Gene Therapy-based Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Gene Therapy-based Drug Revenue, 2017-2028
6.4.2 Germany Gene Therapy-based Drug Market Size, 2017-2028
6.4.3 France Gene Therapy-based Drug Market Size, 2017-2028
6.4.4 U.K. Gene Therapy-based Drug Market Size, 2017-2028
6.4.5 Italy Gene Therapy-based Drug Market Size, 2017-2028
6.4.6 Russia Gene Therapy-based Drug Market Size, 2017-2028
6.4.7 Nordic Countries Gene Therapy-based Drug Market Size, 2017-2028
6.4.8 Benelux Gene Therapy-based Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Gene Therapy-based Drug Revenue, 2017-2028
6.5.2 China Gene Therapy-based Drug Market Size, 2017-2028
6.5.3 Japan Gene Therapy-based Drug Market Size, 2017-2028
6.5.4 South Korea Gene Therapy-based Drug Market Size, 2017-2028
6.5.5 Southeast Asia Gene Therapy-based Drug Market Size, 2017-2028
6.5.6 India Gene Therapy-based Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Gene Therapy-based Drug Revenue, 2017-2028
6.6.2 Brazil Gene Therapy-based Drug Market Size, 2017-2028
6.6.3 Argentina Gene Therapy-based Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene Therapy-based Drug Revenue, 2017-2028
6.7.2 Turkey Gene Therapy-based Drug Market Size, 2017-2028
6.7.3 Israel Gene Therapy-based Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Gene Therapy-based Drug Market Size, 2017-2028
6.7.5 UAE Gene Therapy-based Drug Market Size, 2017-2028
7 Players Profiles
7.1 Biogen
7.1.1 Biogen Corporate Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Gene Therapy-based Drug Major Product Offerings
7.1.4 Biogen Gene Therapy-based Drug Revenue in Global Market (2017-2022)
7.1.5 Biogen Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Gene Therapy-based Drug Major Product Offerings
7.2.4 Novartis Gene Therapy-based Drug Revenue in Global Market (2017-2022)
7.2.5 Novartis Key News
7.3 Gilead Sciences
7.3.1 Gilead Sciences Corporate Summary
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Gene Therapy-based Drug Major Product Offerings
7.3.4 Gilead Sciences Gene Therapy-based Drug Revenue in Global Market (2017-2022)
7.3.5 Gilead Sciences Key News
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Corporate Summary
7.4.2 Sarepta Therapeutics Business Overview
7.4.3 Sarepta Therapeutics Gene Therapy-based Drug Major Product Offerings
7.4.4 Sarepta Therapeutics Gene Therapy-based Drug Revenue in Global Market (2017-2022)
7.4.5 Sarepta Therapeutics Key News
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Corporate Summary
7.5.2 Alnylam Pharmaceuticals Business Overview
7.5.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Major Product Offerings
7.5.4 Alnylam Pharmaceuticals Gene Therapy-based Drug Revenue in Global Market (2017-2022)
7.5.5 Alnylam Pharmaceuticals Key News
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Gene Therapy-based Drug Major Product Offerings
7.6.4 Amgen Gene Therapy-based Drug Revenue in Global Market (2017-2022)
7.6.5 Amgen Key News
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Corporate Summary
7.7.2 Spark Therapeutics Business Overview
7.7.3 Spark Therapeutics Gene Therapy-based Drug Major Product Offerings
7.7.4 Spark Therapeutics Gene Therapy-based Drug Revenue in Global Market (2017-2022)
7.7.5 Spark Therapeutics Key News
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Corporate Summary
7.8.2 Akcea Therapeutics Business Overview
7.8.3 Akcea Therapeutics Gene Therapy-based Drug Major Product Offerings
7.8.4 Akcea Therapeutics Gene Therapy-based Drug Revenue in Global Market (2017-2022)
7.8.5 Akcea Therapeutics Key News
7.9 bluebird bio
7.9.1 bluebird bio Corporate Summary
7.9.2 bluebird bio Business Overview
7.9.3 bluebird bio Gene Therapy-based Drug Major Product Offerings
7.9.4 bluebird bio Gene Therapy-based Drug Revenue in Global Market (2017-2022)
7.9.5 bluebird bio Key News
7.10 Sunway Biotech
7.10.1 Sunway Biotech Corporate Summary
7.10.2 Sunway Biotech Business Overview
7.10.3 Sunway Biotech Gene Therapy-based Drug Major Product Offerings
7.10.4 Sunway Biotech Gene Therapy-based Drug Revenue in Global Market (2017-2022)
7.10.5 Sunway Biotech Key News
7.11 SIBIONO
7.11.1 SIBIONO Corporate Summary
7.11.2 SIBIONO Business Overview
7.11.3 SIBIONO Gene Therapy-based Drug Major Product Offerings
7.11.4 SIBIONO Gene Therapy-based Drug Revenue in Global Market (2017-2022)
7.11.5 SIBIONO Key News
7.12 AnGes
7.12.1 AnGes Corporate Summary
7.12.2 AnGes Business Overview
7.12.3 AnGes Gene Therapy-based Drug Major Product Offerings
7.12.4 AnGes Gene Therapy-based Drug Revenue in Global Market (2017-2022)
7.12.5 AnGes Key News
7.13 Orchard Therapeutics
7.13.1 Orchard Therapeutics Corporate Summary
7.13.2 Orchard Therapeutics Business Overview
7.13.3 Orchard Therapeutics Gene Therapy-based Drug Major Product Offerings
7.13.4 Orchard Therapeutics Gene Therapy-based Drug Revenue in Global Market (2017-2022)
7.13.5 Orchard Therapeutics Key News
7.14 Human Stem Cells Institute
7.14.1 Human Stem Cells Institute Corporate Summary
7.14.2 Human Stem Cells Institute Business Overview
7.14.3 Human Stem Cells Institute Gene Therapy-based Drug Major Product Offerings
7.14.4 Human Stem Cells Institute Gene Therapy-based Drug Revenue in Global Market (2017-2022)
7.14.5 Human Stem Cells Institute Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Gene Therapy-based Drug Market Opportunities & Trends in Global Market
Table 2. Gene Therapy-based Drug Market Drivers in Global Market
Table 3. Gene Therapy-based Drug Market Restraints in Global Market
Table 4. Key Players of Gene Therapy-based Drug in Global Market
Table 5. Top Gene Therapy-based Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Gene Therapy-based Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Gene Therapy-based Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Gene Therapy-based Drug Product Type
Table 9. List of Global Tier 1 Gene Therapy-based Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Therapy-based Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Gene Therapy-based Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Gene Therapy-based Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Gene Therapy-based Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Gene Therapy-based Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Gene Therapy-based Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Gene Therapy-based Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Gene Therapy-based Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Gene Therapy-based Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Gene Therapy-based Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Gene Therapy-based Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Gene Therapy-based Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Gene Therapy-based Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Gene Therapy-based Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Gene Therapy-based Drug Revenue, (US$, Mn), 2023-2028
Table 30. Biogen Corporate Summary
Table 31. Biogen Gene Therapy-based Drug Product Offerings
Table 32. Biogen Gene Therapy-based Drug Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Gene Therapy-based Drug Product Offerings
Table 35. Novartis Gene Therapy-based Drug Revenue (US$, Mn), (2017-2022)
Table 36. Gilead Sciences Corporate Summary
Table 37. Gilead Sciences Gene Therapy-based Drug Product Offerings
Table 38. Gilead Sciences Gene Therapy-based Drug Revenue (US$, Mn), (2017-2022)
Table 39. Sarepta Therapeutics Corporate Summary
Table 40. Sarepta Therapeutics Gene Therapy-based Drug Product Offerings
Table 41. Sarepta Therapeutics Gene Therapy-based Drug Revenue (US$, Mn), (2017-2022)
Table 42. Alnylam Pharmaceuticals Corporate Summary
Table 43. Alnylam Pharmaceuticals Gene Therapy-based Drug Product Offerings
Table 44. Alnylam Pharmaceuticals Gene Therapy-based Drug Revenue (US$, Mn), (2017-2022)
Table 45. Amgen Corporate Summary
Table 46. Amgen Gene Therapy-based Drug Product Offerings
Table 47. Amgen Gene Therapy-based Drug Revenue (US$, Mn), (2017-2022)
Table 48. Spark Therapeutics Corporate Summary
Table 49. Spark Therapeutics Gene Therapy-based Drug Product Offerings
Table 50. Spark Therapeutics Gene Therapy-based Drug Revenue (US$, Mn), (2017-2022)
Table 51. Akcea Therapeutics Corporate Summary
Table 52. Akcea Therapeutics Gene Therapy-based Drug Product Offerings
Table 53. Akcea Therapeutics Gene Therapy-based Drug Revenue (US$, Mn), (2017-2022)
Table 54. bluebird bio Corporate Summary
Table 55. bluebird bio Gene Therapy-based Drug Product Offerings
Table 56. bluebird bio Gene Therapy-based Drug Revenue (US$, Mn), (2017-2022)
Table 57. Sunway Biotech Corporate Summary
Table 58. Sunway Biotech Gene Therapy-based Drug Product Offerings
Table 59. Sunway Biotech Gene Therapy-based Drug Revenue (US$, Mn), (2017-2022)
Table 60. SIBIONO Corporate Summary
Table 61. SIBIONO Gene Therapy-based Drug Product Offerings
Table 62. SIBIONO Gene Therapy-based Drug Revenue (US$, Mn), (2017-2022)
Table 63. AnGes Corporate Summary
Table 64. AnGes Gene Therapy-based Drug Product Offerings
Table 65. AnGes Gene Therapy-based Drug Revenue (US$, Mn), (2017-2022)
Table 66. Orchard Therapeutics Corporate Summary
Table 67. Orchard Therapeutics Gene Therapy-based Drug Product Offerings
Table 68. Orchard Therapeutics Gene Therapy-based Drug Revenue (US$, Mn), (2017-2022)
Table 69. Human Stem Cells Institute Corporate Summary
Table 70. Human Stem Cells Institute Gene Therapy-based Drug Product Offerings
Table 71. Human Stem Cells Institute Gene Therapy-based Drug Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Gene Therapy-based Drug Segment by Type in 2021
Figure 2. Gene Therapy-based Drug Segment by Application in 2021
Figure 3. Global Gene Therapy-based Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gene Therapy-based Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gene Therapy-based Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Therapy-based Drug Revenue in 2021
Figure 8. By Type - Global Gene Therapy-based Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Gene Therapy-based Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Gene Therapy-based Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Gene Therapy-based Drug Revenue Market Share, 2017-2028
Figure 12. US Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Gene Therapy-based Drug Revenue Market Share, 2017-2028
Figure 16. Germany Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Gene Therapy-based Drug Revenue Market Share, 2017-2028
Figure 24. China Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Gene Therapy-based Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Gene Therapy-based Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Gene Therapy-based Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Biogen Gene Therapy-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Gene Therapy-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Gilead Sciences Gene Therapy-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sarepta Therapeutics Gene Therapy-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Alnylam Pharmaceuticals Gene Therapy-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Amgen Gene Therapy-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Spark Therapeutics Gene Therapy-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Akcea Therapeutics Gene Therapy-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. bluebird bio Gene Therapy-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sunway Biotech Gene Therapy-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. SIBIONO Gene Therapy-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. AnGes Gene Therapy-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Orchard Therapeutics Gene Therapy-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Human Stem Cells Institute Gene Therapy-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
